1. Wingo, P.A., Tong, T., and Bolden, S. (1995) Cancer Statistics, 1995,Cancer J. Clinicians 45, 12–13.
2. DeVita, V.T., Hellman, S., and Rosenberg, S.A. (1993) inCANCER, Principles and Practice of Oncology, 4th edn., pp. 1679–1680, J.P. Lippincott Co., Philadelphia.
3. Phuphanich, S., Ferall, S., and Greenberg, H. (1993) Long-Term Survival in Malignant Glioma, Prognostic Factors,J. Fl. Med. Ass. 80, 181–184.
4. Cheeseman, K.H., Burton. G.W., Ingold, K.V., and Slater, T.F. (1984) Lipid Peroxidation and Lipid Antioxidants in Normal and Tumor Cells,Toxicol. Pathol. 12, 235–239.
5. Schroeder, F., and Gardiner, J.M. (1984) Membrane Lipids and Enzymes of Cultured High- and Low-Metastatic B16 Melanoma Variants,Cancer Res. 44, 3262–3269.